Submitted:
25 September 2025
Posted:
29 September 2025
You are already at the latest version
Abstract
Keywords:
Methods
Sample Source
Anesthesia Process
Intubation Protocol
Data Collection
Statistical Analysis
Results
Baseline Characteristics
Comparison of Intubation Success Rates in Different Airway Categories
Comparison of Hemodynamic Parameters
Comparison of Postoperative Recovery
Multivariate Analysis
Discussion
Limitations and Future Directions
Conclusions
- The traditional lung isolation techniques, including the Video-Assisted Double-Lumen Tube (VDLT) and Bronchial Blocker (BO), each have their advantages but also limitations such as airway injury and higher peak airway pressure, especially when used independently.
- Studies have shown the effectiveness of video-assisted intubation in improving success rates and reducing airway injury, but systematic research combining VDLT and BO is limited.
- The study introduces a novel combined approach using VDLT and BO for lung isolation during thoracic surgery. This combination significantly reduces peak airway pressure, shortens positioning time, and improves oxygenation, offering a more effective alternative to single-device methods.
- The VDLT+BO combination not only enhances clinical outcomes, such as lowering postoperative pneumonia rates and reducing recovery time, but also provides significant economic benefits, reducing hospitalization costs by 27.4%.
References
- Xin J, Fan XJ. Effect of visual endotracheal tube combined with bronchial occluder on pulmonary ventilation and arterial blood gas in patients undergoing thoracic surgery. Front Surg. 2023;9:1040224. Published 2023 Jan 6. [CrossRef]
- Purohit A, Bhargava S, Mangal V, Parashar VK. Lung isolation, one-lung ventilation and hypoxaemia during lung isolation. Indian J Anaesth. 2015;59(9):606-617. [CrossRef]
- Palaczynski P, Misiolek H, Szarpak L, et al. Systematic Review and Meta-Analysis of Efficiency and Safety of Double-Lumen Tube and Bronchial Blocker for One-Lung Ventilation. J Clin Med. 2023;12(5):1877. Published 2023 Feb 27. [CrossRef]
- Zhang X, Wang DX, Zhang Q, et al. Effect of intubation in the lateral position under general anesthesia induction on the position of double-lumen tube placement in patients undergoing unilateral video-assisted thoracic surgery: study protocol for a prospective, single-center, parallel group, randomized, controlled trial. Trials. 2023;24(1):67. Published 2023 Jan 29. [CrossRef]
- Ghosh S, Klein AA, Prabhu M, Falter F, Arrowsmith JE. The Papworth BiVent tube: a feasibility study of a novel double-lumen endotracheal tube and bronchial blocker in human cadavers. Br J Anaesth. 2008;101(3):424-428. [CrossRef]
- Knoll H, Ziegeler S, Schreiber JU, et al. Airway injuries after one-lung ventilation: a comparison between double-lumen tube and endobronchial blocker: a randomized, prospective, controlled trial. Anesthesiology. 2006;105(3):471-477. [CrossRef]
- Hunter CL, Nguyen L, Papa L. Comparing Air Medical Personnel Intubation Success Rates Using Direct, Channeled Video-Assisted, and Unchanneled Video-Assisted Laryngoscopy. Air Med J. 2024;43(6):523-527. [CrossRef]
- Dean P, Kerrey B. Video screen visualization patterns when using a video laryngoscope for tracheal intubation: A systematic review. J Am Coll Emerg Physicians Open. 2022;3(1):e12630. Published 2022 Jan 6. [CrossRef]
- Chalkias A, Papagiannakis N, Saugel B, et al. Association of Preoperative Basal Inflammatory State, Measured by Plasma suPAR Levels, with Intraoperative Sublingual Microvascular Perfusion in Patients Undergoing Major Non-Cardiac Surgery. J Clin Med. 2022;11(12):3326. Published 2022 Jun 10. [CrossRef]
- Hua Y, Huang Q, Chen G, Zhu T. Comparison of modified anterior and traditional posterior accesses for ultrasound-guided superior laryngeal nerve block in awake endotracheal intubation: study protocol for a randomised non-inferiority clinical trial. BMJ Open. 2023;13(2):e068779. Published 2023 Feb 28. [CrossRef]
- Lee J, Kwak HJ, Lee JY, Chang MY, Lee SY, Kim JY. Comparison of the Pentax AirwayScope and McGrath MAC videolaryngoscope for endotracheal intubation in patients with a normal airway. Medicine (Baltimore). 2017;96(46):e8713. [CrossRef]
- Risse J, Szeder K, Schubert AK, et al. Comparison of left double lumen tube and y-shaped and double-ended bronchial blocker for one lung ventilation in thoracic surgery-a randomised controlled clinical trial. BMC Anesthesiol. 2022;22(1):92. Published 2022 Apr 2. [CrossRef]
- Wu Y, Liu Y, Ruan H, et al. Efficiency and safety of double-lumen bronchial tube and bronchial blocker for one-lung ventilation in patients with thoracic surgery: a meta-analysis. BMC Anesthesiol. 2025;25(1):281. Published 2025. 31 May. [CrossRef]
- Li H, Chu L, Ye H, et al. Lung isolation with a bronchial blocker placed in the lateral position for patients undergoing thoracic surgery: A multicenter, randomized clinical trial. J Clin Anesth. 2025;104:111869. [CrossRef]
- Clayton-Smith A, Bennett K, Alston RP, et al. A Comparison of the Efficacy and Adverse Effects of Double-Lumen Endobronchial Tubes and Bronchial Blockers in Thoracic Surgery: A Systematic Review and Meta-analysis of Randomized Controlled Trials. J Cardiothorac Vasc Anesth. 2015;29(4):955-966. [CrossRef]
- Nowak-Tim J, Gaszynski T, Ratajczyk P. A comparison of face-to-face endotracheal intubation and standard intubation using Airtraq video laryngoscope in morbidly obese patients: A randomized controlled trial. Medicine (Baltimore). 2022;101(48):e32046. [CrossRef]
- Gaszyński T, Gómez-Ríos MÁ, Serrano-Moraza A, Sastre JA, López T, Ratajczyk P. New Devices, Innovative Technologies, and Non-Standard Techniques for Airway Management: A Narrative Review. Healthcare (Basel). 2023;11(18):2468. Published 2023 Sep 5. [CrossRef]
- Liang F, Zheng S, Li J, Xiao XS, Wen LH, Lin JG. Application of visible single-lumen tube combined with bronchial occluder in one-lung ventilation surgery. Guangdong Med J. (2019) 40:1791–4. [CrossRef]




| Characteristic | Group | ||
|---|---|---|---|
| VDLT N = 451 |
BO N = 451 |
VDLT_BO N = 451 |
|
| Age | 47.58 ± 8.20 | 43.23 ± 9.99 | 44.93 ± 9.74 |
| BMI | 23.60 (23.12, 23.97) | 23.02 (21.75, 24.29) | 23.31 (22.50, 24.70) |
| SBP | 93.49 ± 9.29 | 96.27 ± 6.44 | 91.97 ± 11.53 |
| DBP | 147.18 ± 10.21 | 147.18 ± 8.76 | 148.60 ± 10.25 |
| Hypertension duration | 3.61 ± 1.71 | 4.06 ± 1.32 | 3.81 ± 1.07 |
| MAP | 81.21 ± 3.58 | 79.28 ± 5.87 | 82.02 ± 3.96 |
| HR | 81.94 (79.08, 82.92) | 85.68 (79.90, 91.29) | 82.46 (80.95, 83.96) |
| SpO2 | 87.50 ± 2.37 | 86.63 ± 3.87 | 87.71 ± 3.14 |
| PaCO2 | 31.23 (29.82, 33.51) | 36.95 (28.25, 38.68) | 33.18 (32.12, 34.71) |
| PaO2 | 73.40 ± 3.64 | 73.69 ± 4.74 | 74.09 ± 3.54 |
| FEV1 | 2.57 (2.37, 2.71) | 2.27 (2.03, 2.61) | 2.35 (2.18, 2.48) |
| FVC | 3.25 (3.04, 3.36) | 3.27 (3.09, 3.48) | 3.28 (3.10, 3.30) |
| Gender | |||
| Male | 26 (57.8%) | 28 (62.2%) | 28 (62.2%) |
| Female | 19 (42.2%) | 17 (37.8%) | 17 (37.8%) |
| Myocardial infarction | |||
| No | 41 (91.1%) | 40 (88.9%) | 38 (84.4%) |
| Yes | 4 (8.9%) | 5 (11.1%) | 7 (15.6%) |
| ASA | |||
| Ⅱ | 11 (24.4%) | 17 (37.8%) | 13 (28.9%) |
| Ⅲ | 30 (66.7%) | 27 (60.0%) | 27 (60.0%) |
| Ⅳ | 4 (8.9%) | 1 (2.2%) | 5 (11.1%) |
| Smoking | |||
| No | 23 (51.1%) | 19 (42.2%) | 26 (57.8%) |
| Yes | 22 (48.9%) | 26 (57.8%) | 19 (42.2%) |
| Alcoholism | |||
| No | 28 (62.2%) | 19 (42.2%) | 30 (66.7%) |
| Yes | 17 (37.8%) | 26 (57.8%) | 15 (33.3%) |
| Characteristic | BO N = 45 |
VDLT N = 45 |
VDLT_BO | Statistic1 | p-value |
|---|---|---|---|---|---|
| N = 45 | |||||
| Pain score, Mean ± SD | 4.66 ± 0.61 | 5.34 ± 0.62 | 3.73 ± 0.93 | 55.09 | <0.0012 |
| Hospital stay, Mean ± SD | 5.05 ± 0.83 | 7.67 ± 1.01 | 4.24 ± 1.07 | 152 | <0.0012 |
| Hospital cost, Mean ± SD | 7,694.82 ± 921.31 | 9,155.16 ± 1,629.53 | 6,642.53 ± 1,248.81 | 42.45 | <0.0012 |
| Wbc abnormal, n (%) | 12.89 | 0.0023 | |||
| Abnormal | 21 (46.7%) | 30 (66.7%) | 13 (28.9%) | ||
| Normal | 24 (53.3%) | 15 (33.3%) | 32 (71.1%) | ||
| pneumonia, n (%) | 6 | 0.0503 | |||
| No | 41 (91.1%) | 34 (75.6%) | 41 (91.1%) | ||
| Yes | 4 (8.9%) | 11 (24.4%) | 4 (8.9%) |
| Variables | β | S.E | t | P | β (95%CI) |
|---|---|---|---|---|---|
| Intercept | 73.24 | 2.09 | 35.1 | <.001 | 73.24 (69.15 ~ 77.33) |
| Group | |||||
| VDLT | 0.00 (Reference) | ||||
| BO | 3.14 | 0.96 | 3.28 | 0.001 | 3.14 (1.27 ~ 5.02) |
| VDLT_BO | 4.7 | 0.95 | 4.96 | <.001 | 4.70 (2.84 ~ 6.55) |
| Age | 0.12 | 0.04 | 2.83 | 0.005 | 0.12 (0.04 ~ 0.20) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).